A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS

• Eoghan de Barra ,

  * E-mail: edebarra@rcsi.ie

  Affiliation Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Susanne H. Hodgson,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Katie J. Ewer,

  Affiliation The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom

  ⨯
• Carly M. Bliss,

  Affiliation The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom

  ⨯
• Kerrie Hennigan,

  Affiliation Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Ann Collins,

  Affiliation Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Eleanor Berrie,

  Affiliation Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Alison M. Lawrie,

  Affiliation Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

  ⨯
• Sarah C. Gilbert,

  Affiliation The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom

  ⨯
• Alfredo Nicosia,

  Affiliations Okairòs AG, Rome, Italy, CEINGE, Naples, Italy

  ⨯
• Samuel J. McConkey ,

  Contributed equally to this work with: Samuel J. McConkey, Adrian V. S. Hill

  Affiliation Royal College of Surgeons in Ireland, Dublin, Ireland

  ⨯
• Adrian V. S. Hill

  Contributed equally to this work with: Samuel J. McConkey, Adrian V. S. Hill

  Affiliation The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, United Kingdom

  ⨯